KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Merck (MRK) EPS (Basic) (2016 - 2025)

Merck (MRK) has disclosed EPS (Basic) for 17 consecutive years, with $1.2 as the latest value for Q4 2025.

  • On a quarterly basis, EPS (Basic) fell 18.92% to $1.2 in Q4 2025 year-over-year; TTM through Dec 2025 was $7.3, a 7.99% increase, with the full-year FY2025 number at $7.3, up 7.99% from a year prior.
  • EPS (Basic) was $1.2 for Q4 2025 at Merck, down from $2.32 in the prior quarter.
  • In the past five years, EPS (Basic) ranged from a high of $2.32 in Q3 2025 to a low of -$2.35 in Q2 2023.
  • A 5-year average of $1.24 and a median of $1.48 in 2021 define the central range for EPS (Basic).
  • Peak YoY movement for EPS (Basic): surged 5066.67% in 2021, then crashed 250.64% in 2023.
  • Merck's EPS (Basic) stood at $1.49 in 2021, then dropped by 20.81% to $1.18 in 2022, then tumbled by 141.53% to -$0.49 in 2023, then soared by 402.04% to $1.48 in 2024, then fell by 18.92% to $1.2 in 2025.
  • Per Business Quant, the three most recent readings for MRK's EPS (Basic) are $1.2 (Q4 2025), $2.32 (Q3 2025), and $1.77 (Q2 2025).